Arkolith/Insider Trading/BLPH/Form 4

Kim Bobae

VP Reg. Affairs & QualityBellerophon Therapeutics, Inc. (BLPH) · full profile →Form 4 · filed May 22, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$95K
Net Open-Market Flow
-$95K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2023Option exercise(M)1K$7.50$8K2K
May 18, 2023Option exercise(M)266$7.35$2K2K
May 18, 2023Sell(S)9K$10.00$95K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 18, 2023Option exercise(M)1K—$0144
May 18, 2023Option exercise(M)266—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-063263) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML